IO Health™ Raises $2M Seed Round to Scale Real-time Quality Platform

Los Angeles-based IO Health™ Technologies has closed a $2 million seed round, led by Nina Capital, to expand its AI-driven compliance and quality platform for home health and hospice providers.

Founded in 2023 by home health veterans, IO Health™ develops tools to optimize clinical, operational and financial performance. Their novel patent-pending technology delivers productivity to clinicians in real time at the point of care, without requiring lengthy implementation, clinician retraining or EMR replacement.

According to CEO Dr. David Bell, the technology is designed to meet one of the industry’s most pressing challenges: delivering better patient experience in the face of compliance demands, shrinking margins and staff shortages. Agencies know they need to improve quickly to survive.

“We designed IO Health to address the single biggest lever of improvement: accurate documentation. Better documentation means less back-office workload, faster billing, and happier clinicians.” According to Dr. Bell. “Accurate, compliant documentation produces 4-5x better clinical and financial results than efficiency alone.”

Customers like Mark Hunt, President of Elevate Home Health, have been enthusiastic: “we have seen a significant improvement in accuracy of our functional scores, clinician efficiency and the QA team’s workload.”

Customer data from early deployments point to measurable outcomes:

• 25% reduction in QA rework loops
• 36% lower clinician turnover

Nina Capital, with offices in Barcelona and Silicon Valley, focuses on health tech innovation with multi-national market opportunities. Nina was drawn to IO Health’s operator-led approach.

“IO Health’s model addresses compliance and documentation at the source — not after the fact. Its unique architecture addresses a core problem in care delivery: the disconnect between field-level care and financial outcomes, aligned with patient acuity,” says Marta G. Zanchi, Managing Partner of Nina Capital. “We believe it can set a new standard in post-acute care and prove its value as an indispensable layer of infrastructure for the home health ecosystem.”

The founding team’s deep operational expertise is soon to be expanded even further with the addition of Marc Subirats, General Partner of Nina Capital, to the IO Health Board of Directors. “As the founder and former CEO of Advance Medical, a global leader in virtual care services (acquired by Teladoc Health), my partner Marc Subirats understands firsthand the challenges of scaling in the healthcare ecosystem. His experience will be a tremendous asset to IO Health as they grow,” adds Dr. Zanchi.

The funding will be used to expand IO Health™’s Care Optimized suite for home health and hospice, which includes:

• ioAssist™ for point-of-care validation, compliance and best practice education (including HOPE starting Oct 1 for hospice)
• ioIQ™ for QA optimization
• ioDoc™ for automated patient handbooks

The U.S. home health sector, projected to exceed $150 billion annually by 2030, faces rising regulatory requirements and mounting financial strain. Industry operators have increasingly sought workflow technologies that integrate with existing EMRs rather than replace them.

IO Health™ joins a growing group of “intelligent overlay” startups, but differentiates itself with what Bell calls “compliance, education, and quality tools that drive bottom-line results.” The company’s flagship product, ioAssist™, overlays existing EMRs and provides real-time validation, education and best practices to clinicians in the field.

“Post-acute providers don’t need extra applications for clinicians to log into or big workflow changes.” Bell said. “We need help.”